BullFrog AI Holdings (BFRGW) Share-based Compensation Growth (1y) (2022 - 2025)
Powered by 
Analysis
BullFrog AI Holdings (BFRGW) Share-based Compensation Growth (1y) (2022 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.04 Bn | 197.05 Bn | 7.24 Bn | 19.90% |
| 2 | Gilead Sciences | 181.32 Bn | 178.14 Bn | 6.22 Bn | 2.67% |
| 3 | Vertex Pharmaceuticals | 132.20 Bn | 124.35 Bn | 2.84 Bn | 71.86% |
| 4 | Regeneron Pharmaceuticals | 82.41 Bn | 74.42 Bn | 3.93 Bn | -3.46% |
| 5 | Argenx Se | 61.58 Bn | 56.39 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.71 Bn | 49.57 Bn | 52.00 Mn | -7.69% |
| 7 | Alnylam Pharmaceuticals | 34.15 Bn | 30.84 Bn | 992.69 Mn | -22.43% |
| 8 | Biogen | 31.25 Bn | 29.97 Bn | 1.96 Bn | 3.34% |
| 9 | Roivant Sciences | 30.09 Bn | 30.09 Bn | 1.16 Mn | - |
| 10 | BullFrog AI Holdings | 1.84 Mn | -5.08 Mn | 106,899.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -28.03% |
| Sep 30, 2025 | 2.00% |
| Jun 30, 2025 | 13.00% |
| Mar 31, 2025 | 13.57% |
| Dec 31, 2024 | 78.04% |
| Sep 30, 2024 | 67.30% |
| Jun 30, 2024 | 85.18% |
| Mar 31, 2024 | 225.84% |
| Dec 31, 2023 | 144.25% |
| Sep 30, 2023 | 885.17% |
| Jun 30, 2023 | 99,393.79% |
| Mar 31, 2023 | 745.24% |
| Dec 31, 2022 | -89.48% |